PASITHEA THERAPEUTICS CORP. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
PASITHEA THERAPEUTICS CORP. (KTTA) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $18.77 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2026-03-30
- PASITHEA THERAPEUTICS CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-12-31 was -$6.71K.
- PASITHEA THERAPEUTICS CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-09-30 was $12.67K.
- PASITHEA THERAPEUTICS CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-06-30 was $5.63K.
- PASITHEA THERAPEUTICS CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-03-31 was $7.17K.
- PASITHEA THERAPEUTICS CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2025 was $18.77K.
- PASITHEA THERAPEUTICS CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2024 was -$2.52K.
- PASITHEA THERAPEUTICS CORP. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2023 was -$3.99K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$6.71K derived: 10-K 12 month − 3 quarters · filed 2026-03-30 | $5.96K derived: sum of 2 quarters · filed 2026-03-30 | $11.60K derived: sum of 3 quarters · filed 2026-03-30 | $18.77K 10-K · filed 2026-03-30 |
| 2025-09-30 | $12.67K 10-Q · filed 2025-11-13 | $18.30K derived: sum of 2 quarters · filed 2025-11-13 | $25.47K derived: sum of 3 quarters · filed 2025-11-13 | |
| 2025-06-30 | $5.63K 10-Q · filed 2025-11-13 | $12.80K derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2025-03-31 | $7.17K 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | -$2.52K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | -$27.13K 10-Q · filed 2025-11-13 | -$30.05K derived: sum of 2 quarters · filed 2025-11-13 | -$30.66K derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$2.91K 10-Q · filed 2025-11-13 | -$3.53K derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | -$620.00 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | -$3.99K 10-K · filed 2025-03-24 | |||
| 2023-09-30 | -$4.26K 10-Q · filed 2024-11-13 | -$4.57K derived: sum of 2 quarters · filed 2024-11-13 | -$7.06K derived: sum of 3 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$317.00 10-Q · filed 2024-11-13 | -$2.80K derived: sum of 2 quarters · filed 2024-11-13 | ||
| 2023-03-31 | -$2.48K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |